Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

N-butyl-N-(4-hydroxybutyl) NitrosamineÀ¸·Î À¯¹ß½ÃŲ ÁãÀÇ ¹æ±¤¾Ï¿¡¼­ Magnolia officinalis ÃßÃâ¹°ÀÇ Ç×¾ÏÈ¿°ú Anticancer Effect of Magnolia officinalis¡¯ Extract on N-butyl-N-(4-hydroxybutyl) Nitrosamine Induced Bladder Cancer in Mice

´ëÇѺñ´¢±â°úÇÐȸÁö 2008³â 49±Ç 8È£ p.682 ~ 687
À̽ÂÂù, Á¤ÇʵÎ, ±è¿ëÁØ, À±¼®Áß, ÀÌ»óö, ±è¿øÀç,
¼Ò¼Ó »ó¼¼Á¤º¸
À̽ÂÂù ( Lee Seung-Chan ) 
Chungbuk National University

Á¤ÇʵΠ( Jung Pil-Du ) 
Chungbuk National University
±è¿ëÁØ ( Kim Yong-June ) 
Chungbuk National University
À±¼®Áß ( Yun Seok-Joong ) 
Chungbuk National University
ÀÌ»óö ( Lee Sang-Cheol ) 
Chungbuk National University
±è¿øÀç ( Kim Wun-Jae ) 
Chungbuk National University

Abstract


Purpose: Magnolia officinalis has been used in traditional Chinese medicine to treat a variety of diseases. The main constituents of Magnolia officinalis are honokiol and magnolol, which have a variety of pharmacological effects, such as antitumor, antioxidant, antimicrobial, anti-inflammatory etc. This study examined the anticancer effect of a Magnolia officinalis¡¯ extract on urinary bladder cancer in vivo. Materials and

Methods: Male mice C3H/He were used as the experimental animals. The mice were divided into ten groups. Normal drinking water was provided to group 1(5 mice) for 20 weeks and 0.05% N-butyl- N-(4-hydroxybutyl) nitrosamine(BBN) was added to in the drinking water of group 2(5 mice). 0.1, 0.3, 1.0 and 3.0% Magnolia officinalis¡¯ extract was added to groups 3, 4, 5 and 6, respectively(5 mice each), and 0.1, 0.3, 1.0 and 3.0% Magnolia officinalis¡¯ extract plus 0.05% BBN was added to groups 7, 8, 9 and 10, respectively(10 mice each) for the same period. All surviving mice were sacrificed at week 20 to investigate the occurrence of bladder cancer, stage and grade.

Results: Bladder cancer was not observed in groups 1, 3, 4, 5 and 6 mice. The rates of bladder cancer occurrence were 57.1, 66.7, 44.4 and 20.0% in groups 7, 8, 9 and 10, respectively. The incidence decreased with increasing concentration of Magnolia officinalis (p=0.005). However, the stage and grade were not associated with the concentration of Magnolia officinalis(each p£¾0.05).

Conclusions: This study showed that Magnolia officinalis has some protective effect against bladder cancer. In the future, Magnolia officinalis may be expected to play an important role as a chemo-preventive and therapeutic agent or as a complementary agent in bladder cancer. (Korean J Urol 2008;49:682-687)

Å°¿öµå

Magnolia officinalis;Bladder cancer;N-butyl-N-(4-hydroxybutyl) nitrosamine

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS